SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-127972
Filing Date
2022-12-16
Accepted
2022-12-16 18:16:46
Documents
1
Period of Report
2022-12-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2232925-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2232925-2_4seq1.xml 4 3961
  Complete submission text file 0001104659-22-127972.txt   5907
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Issuer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ELYS GAME TECHNOLOGY CORP. 130 ADELAIDE STREET WEST, SUITE 701 TORONTO A6 M5H2K4
Business Address C/O ELYS GAME TECHNOLOGY CORP. 130 ADELAIDE STREET WEST, SUITE 701 TORONTO A6 M5H2K4 301 944 6600
SHALLCROSS STEVEN A (Reporting) CIK: 0001263501 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12584 | Film No.: 221469201